Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

ATM and breast cancer susceptibility

Oncogene volume 25, pages 5906–5911 (2006)Cite this article

Abstract

ATM was originally identified by positional cloning as the gene that underlies the autosomal recessive condition ataxia-telangiectasia. The encoded protein plays a central role in the complex processes that repair DNA double-strand breaks. Nearly 20 years ago, epidemiological surveys of relatives of ataxia-telangiectasia cases suggested that female relatives were at modestly increased risk of breast cancer. Subsequently, many studies have tried to clarify the role of ATM in breast cancer susceptibility, but have produced inconclusive and/or inconsistent results. Recently, large epidemiological and molecular studies have finally provided conclusive evidence that ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Abraham RT . (2004). DNA Repair (Amsterdam) 3: 883–887.

  • Allinen M, Launonen V, Laake K, Jansen L, Huusko P, Kaariainen H et al. (2002). J Med Genet 39: 192–196.

  • Antoniou A, Easton DF . (2006). Oncogene 25: 5898–5905.

  • Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M et al. (2003). Cancer Res 63: 8717–8725.

  • Bakkenist CJ, Kastan MB . (2003). Nature 421: 499–506.

  • Bay JO, Grancho M, Pernin D, Presneau N, Rio P, Tchirkov A et al. (1998). Int J Oncol 12: 1385–1390.

  • Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone KE, Teitelbaum SL et al. (2003). Br J Cancer 89: 1513–1516.

  • Bosotti R, Isacchi A, Sonnhammer FL . (2000). Trends Biochem Sci 25: 225–227.

  • Bretsky P, Haiman CA, Gilad S, Yahalom J, Grossman A, Paglin S et al. (2003). Cancer Epidemiol Biomarkers Prev 12: 733–738.

  • Broeks A, Urbanus JH, Floore AN, Dahler EC, Klijn JG, Rutgers EJ et al. (2000). Am J Hum Genet 66: 494–500.

  • Buchholz TA, Weil MM, Ashorn CL, Strom EA, Sigurdson A, Bondy M et al. (2004). Cancer 100: 1345–1351.

  • Chen J, Birkholtz GG, Lindblom P, Rubio C, Lindblom A . (1998). Cancer Res 58: 1376–1379.

  • Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X et al. (2002). J Natl Cancer Inst 94: 205–215.

  • Chun HH, Gatti RA . (2004). DNA repair (Amsterdam) 3: 1187–1196.

  • Domchek SM, Weber BL . (2006). Oncogene 25: 5825–5831.

  • Dork T, Bendix R, Bremer M, Rades D, Klopper K, Nicke M et al. (2001). Cancer Res 61: 7608–7615.

  • Drumea KC, Levine E, Bernstein J, Shank B, Green S, Kaplan E et al. (2000). Breast Cancer Res Treat 61: 79–85.

  • Easton DF . (1994). Int J Radiat Biol 66: S177–S182.

  • Fernandes N, Sun Y, Chen S, Paul P, Shaw RJ, Cantley LC et al. (2005). J Biol Chem 280: 15158–15164.

  • FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP et al. (1997). Nat Genet 15: 307–310.

  • Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P et al. (1988). Nature 336: 577–580.

  • Gatti RA, Tward A, Concannon P . (1999). Mol Genet Metab 68: 419–423.

  • Geoffroy-Perez B, Janin N, Ossian K, Lauge A, Croquette MF, Griscelli C et al. (2001). Int J Cancer 93: 288–293.

  • Gudmundsdottir K, Ashworth A . (2006). Oncogene 25: 5864–5874.

  • Gutierrez-Enriquez S, Fernet M, Dork T, Bremer M, Lauge A, Stoppa-Lyonnet D et al. (2004). Genes Chromosomes Cancer 40: 109–119.

  • Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS . (2002). Int J Radiat Oncol Biol Phys 52: 606–613.

  • Izatt L, Greenman J, Hodgson S, Ellis D, Watts S, Scott G et al. (1999). Genes Chromosomes Cancer 26: 286–294.

  • Jeggo PA, Lobrich M . (2006). DNA Repair (Amsterdam), in press [Epub ahead of print].

  • Jiang X, Sun Y, Chen S, Roy K, Price BD . (2006). J Biol Chem 281: 15741–15746.

  • Kurz EU, Lees-Miller SP . (2004). DNA Repair (Amsterdam) 3: 889–900.

  • Laake K, Vu P, Andersen TI, Erikstein B, Karesen R, Lonning PE et al. (2000). Br J Cancer 83: 1650–1653.

  • Lavin MF, Scott S, Gueven N, Kozlov S, Peng C, Chen P . (2004). DNA Repair (Amsterdam) 3: 1197–1205.

  • Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY et al. (2005). Cancer Epidemiol Biomarkers Prev 14: 821–825.

  • Lindeman GJ, Hiew M, Visvader JE, Leary J, Field M, Gaff CL et al. (2004). Breast Cancer Res 6: R401–R407.

  • Maillet P, Bonnefoi H, Vaudan-Vutskits G, Pajk B, Cufer T, Foulkes WD et al. (2002). J Med Genet 39: 751–753.

  • Meyer A, John E, Dork T, Sohn C, Karstens J, Bremer M . (2004). Radiol Oncol 72: 319–323.

  • Morrell D, Cromartie E, Swift M . (1986). J Natl Cancer Inst 77: 89–92.

  • Neubauer S, Arutyunyan R, Stumm M, Dork T, Bendix R, Bremer M et al. (2002). Radiat Res 157: 312–321.

  • Nevanlinna H, Bartek J . (2006). Oncogene Rev 25: 5912–5919.

  • Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K et al. (2002). Clin Cancer Res 8: 3813–3819.

  • Olsen JH, Hahnemann JM, Borresen-Dale AL, Brondum-Nielsen K, Hammarstrom L, Kleinerman R et al. (2001). J Natl Cancer Inst 93: 121–127.

  • Olson JH, Hahnemann JMD, Borresen-Dale A-L, Tretli S, Kelinerman R, Sankila R et al. (2005). Br J Cancer 93: 260–265.

  • Perry J, Kleckner N . (2003). Cell 112: 151–155.

  • Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M et al. (2006). Nat Genet, in press [Epub ahead of print].

  • Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L et al. (1995). Science 268: 1749–1753.

  • Shafman TD, Levitz S, Nixon AJ, Gibans LA, Nichols KE, Bell DW et al. (2000). Genes Chromosomes Cancer 27: 124–129.

  • Shayeghi M, Seal S, Regan J, Collins N, Barfoot R, Rahman N et al. (1998). Br J Cancer 78: 922–927.

  • Shiloh Y . (2006). Trends Biochem Sci 31: 402–410.

  • Sommer SS, Buzin CH, Jung M, Zheng J, Liu Q, Jeong SJ et al. (2002). Cancer Genet Cytogenet 134: 25–32.

  • Sommer SS, Jiang Z, Feng J, Buzin CH, Zheng J, Longmate J et al. (2003). Cancer Genet Cytogenet 145: 115–120.

  • Speit G, Trenz K, Schultz P, Bendix R, Dork T . (2000). Cytogenet Cell Genet 91: 261–266.

  • Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B et al. (2002). Breast Cancer Res 4: R15.

  • Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P et al. (1998). Am J Hum Genet 62: 334–345.

  • Stewart GS, Last JI, Stankovic T, Haites N, Kidd AM, Byrd PJ et al. (2001). J Biol Chem 276: 30133–30141.

  • Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT . (1986). Am J Hum Genet 39: 573–583.

  • Swift M, Morrell D, Massey RB, Chase CL . (1991). N Engl J Med 325: 1831–1836.

  • Swift M, Reitnauer PJ, Morrell D, Chase CL . (1987). N Engl J Med 316: 1289–1294.

  • Swift M, Sholman L, Perry M, Chase C . (1976). Cancer Res 36: 209–215.

  • Szabo CI, Schutte M, Broeks A, Houwing-Duistermaat JJ, Thorstenson YR, Durocher F et al. (2004). Cancer Res 64: 840–843.

  • Tamimi RM, Hankinson SE, Spiegelman D, Kraft P, Colditz GA, Hunter DJ . (2004). Breast Cancer Res 6: R416–R422.

  • Taylor AM, Byrd PJ . (2005). J Clin Pathol 58: 1009–1015.

  • Teraoka SN, Malone KE, Doody DR, Suter NM, Ostrander EA, Daling JR et al. (2001). Cancer 92: 479–487.

  • Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T et al. (2005a). Hum Mutat 25: 594–595.

  • Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A et al. (2005b). J Natl Cancer Inst 97: 813–822.

  • Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T et al. (2003). Cancer Res 63: 3325–3333.

  • Vorechovsky I, Luo L, Lindblom A, Negrini M, Webster AD, Croce CM et al. (1996). Cancer Res 56: 4130–4133.

Download references

Author information

Authors and Affiliations

  1. Section of Cancer Genetics, Institute of Cancer Research, Sutton, UK

    M Ahmed & N Rahman

Authors
  1. M Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N Rahman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahmed, M., Rahman, N. ATM and breast cancer susceptibility. Oncogene 25, 5906–5911 (2006). https://doi.org/10.1038/sj.onc.1209873

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209873

Keywords

This article is cited by

Search

Advanced search

Quick links